Literature DB >> 1371684

Nitric oxide but not prostacyclin is an autocrine endothelial mediator.

H Schröder1, H Strobach, K Schrör.   

Abstract

Using porcine aortic endothelial cells, the present study investigates whether stimulation of prostacyclin (PGI2) and nitric oxide also causes elevation of the respective second messengers cAMP and cGMP in the endothelial generator cells. The calcium ionophore A23187 at 0.3-3 microM increased endothelial cGMP levels up to 27-fold in an L-arginine-dependent manner as assessed through complete inhibition by NG-monomethyl-L-arginine (100 microM). The 36-fold PGI2 stimulation by 3 microM A23187 was not accompanied by an intracellular increase in cAMP or an enhanced cAMP efflux. Correspondingly, the PGI2 mimetic iloprost (10 pM-100 microM) did not change endothelial cAMP levels. However, forskolin (1-100 microM) and prostaglandin E2 (PGE2) (0.1-10 microM) produced concentration-dependent increases in cAMP with a 9-fold and 8-fold stimulation at 100 microM forskolin and 10 microM PGE2, respectively. These results demonstrate that in contrast to NO, PGI2 acts as a strictly paracrine hormone without affecting the respective second messenger cAMP in the endothelial generator cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371684     DOI: 10.1016/0006-2952(92)90575-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Acute and chronic exposure to shear stress have opposite effects on endothelial permeability to macromolecules.

Authors:  Christina M Warboys; R Eric Berson; Giovanni E Mann; Jeremy D Pearson; Peter D Weinberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

2.  Prostacyclin-dependent cyclic AMP formation in endothelial cells.

Authors:  H Schröder; K Schrör
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

3.  N-acetyl-L-cysteine protects endothelial cells but not L929 tumor cells from tumor necrosis factor-alpha-mediated cytotoxicity.

Authors:  H Schröder; S Warren; M J Bargetzi; S V Torti; F M Torti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

4.  S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.

Authors:  R Heller; F Bussolino; R Calvino; D Ghigo; P Alessio; R Todde; R Fruttero; G Pescarmona; A Gasco; U Till
Journal:  Agents Actions       Date:  1993-11

5.  The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia. A double-blind, placebo-controlled, prospective study.

Authors:  D Kaczmarek; T Hohlfeld; G Wambach; K Schrör
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.